Creator Post Archive
Martin Shkreli
Browse the full post archive, then jump into the source post to inspect linked mentions and linked signals.
Apr 6, 2026
4/6/26 - sorry for the wait!
Martin Shkreli returns after an illness, discussing various topics including biotech deals, drug development, and personal health regimens. He touches on Seleno acquisition by Nurocran, Lightwave Logic, Amgen's execution, and mentions Biogen and Viatris with some commentary.
4 mentions · 1 linked signals
Mar 20, 2026
3/20/26 - sorry for the wait!
The creator discusses several companies including Super Micro, Planet Labs, Moderna, Denali, and Arrowhead. He expresses surprise at Super Micro's stock drop, notes Planet Labs' record revenue, and highlights Arrowhead as a significant past winner and Surreptit's partner.
21 mentions · 6 linked signals
Feb 25, 2026
2/25/26 - NVDA earnings release
Dry-run Step 5 insert for NVDA
3 mentions · 0 linked signals